Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.
Institute of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, 475000, Henan, China.
Mil Med Res. 2020 Apr 4;7(1):17. doi: 10.1186/s40779-020-00245-9.
On 6 February 2020, our team had published a rapid advice guideline for diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infection, and this guideline provided our experience and make well reference for fighting against this pandemic worldwide. However, the coronavirus disease 2019 (COVID-19) is a new disease, our awareness and knowledge are gradually increasing based on the ongoing research findings and clinical practice experience; hence, the strategies of diagnosis and treatment are also continually updated. In this letter, we answered one comment on our guideline and provided the newest diagnostic criteria of "suspected case" and "confirmed case" according to the latest Diagnosis and Treatment Guidelines for COVID-19 (seventh version) that issued by the National Health Committee of the People's Republic of China.
2020 年 2 月 6 日，我们团队发布了 2019 年新型冠状病毒（2019-nCoV）感染的快速诊断和治疗指南，该指南为全球抗击这一流行疾病提供了我们的经验和参考。然而，新型冠状病毒肺炎（COVID-19）是一种新的疾病，我们的认识和知识正基于正在进行的研究结果和临床实践经验逐渐增加；因此，诊断和治疗策略也在不断更新。在这封信中，我们回应了对我们指南的一条评论，并根据中华人民共和国国家卫生健康委员会发布的《新型冠状病毒肺炎诊疗方案（试行第七版）》提供了最新的“疑似病例”和“确诊病例”的诊断标准。
